| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Charles P O'brien | |
| P304 | page(s) | 28-33 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | The Journal of Clinical Psychiatry | Q7743563 |
| P1476 | title | Benzodiazepine use, abuse, and dependence | |
| P478 | volume | 66 Suppl 2 |
| Q24644809 | Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond |
| Q45056140 | Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats |
| Q37493431 | Acetaminophen for self-reported sleep problems in an elderly population (ASLEEP): study protocol of a randomized placebo-controlled double-blind trial |
| Q24684698 | Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist |
| Q40155642 | Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA (A) receptors. |
| Q41943782 | Alprazolam withdrawal delirium and brief reversible psychosis: a case report |
| Q43042971 | Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator |
| Q36443151 | Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study |
| Q44345419 | Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder |
| Q54636663 | Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs. |
| Q90565653 | Benzodiazepine Use and Misuse Among Adults in the United States |
| Q35489297 | Benzodiazepine dependence among multidrug users in the club scene |
| Q26828580 | Benzodiazepine harm: how can it be reduced? |
| Q35740007 | Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland |
| Q36032982 | Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000-2010. |
| Q60934498 | Benzodiazepine receptor agonist dispensations in Alberta: a population-based descriptive study |
| Q37565076 | Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes |
| Q36874241 | Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation |
| Q64941989 | Benzodiazepine use, misuse, and abuse: A review. |
| Q47553853 | Benzodiazepines for antipsychotic-induced tardive dyskinesia. |
| Q39172105 | CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers |
| Q24633884 | Cannabinoids in health and disease |
| Q30525101 | Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects |
| Q43248865 | Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report |
| Q47427824 | Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study |
| Q24647208 | Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review |
| Q91713306 | County and Physician Variation in Benzodiazepine Prescribing to Medicare Beneficiaries by Primary Care Physicians in the USA |
| Q99585315 | Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development |
| Q36807384 | Diversion of benzodiazepines through healthcare sources |
| Q34458582 | Down-Regulation of Synaptic GluN2B Subunit-Containing N-methyl-d-aspartate Receptors: A Physiological Brake on CA1 Neuron α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Hyperexcitability during Benzodiazepine Withdrawal |
| Q33946973 | Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery |
| Q30497060 | Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety |
| Q33413080 | Educating and informing patients receiving psychopharmacological medications: are family physicians in Pakistan up to the task? |
| Q34381998 | Effect of Neurexan on the pattern of EEG frequencies in rats |
| Q36930875 | Effects of the combination of metyrapone and oxazepam on cocaine and food self-administration in rats |
| Q36298192 | Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats. |
| Q28264334 | GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons |
| Q34569409 | GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area |
| Q47732092 | GABAA receptor positive allosteric modulators modify the abuse-related behavioral and neurochemical effects of methamphetamine in rhesus monkeys |
| Q34311279 | Heavy use versus less heavy use of sedatives among non-medical sedative users: Characteristics and correlates |
| Q44346195 | High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City |
| Q35837717 | High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment. |
| Q35629095 | High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal. |
| Q24631269 | How addictive drugs disrupt presynaptic dopamine neurotransmission |
| Q88811932 | Implementation of an Opioid Detoxification Management Pathway Reduces Emergency Department Length of Stay |
| Q34335439 | Lormetazepam addiction: data analysis from an Italian medical unit for addiction |
| Q45045914 | Low risk of development of substance dependence for barbiturates and clobazam prescribed as antiepileptic drugs: results from a questionnaire study |
| Q35044233 | Melancholic and reactive depression: a reappraisal of old categories |
| Q40643023 | Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers |
| Q34699990 | Mother's little helper? Contrasting accounts of benzodiazepine and methadone use among drug-dependent parents in the UK. |
| Q35843517 | Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia. |
| Q33855956 | Neural bases for addictive properties of benzodiazepines. |
| Q30580823 | Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens. |
| Q36911401 | Neuropsychiatric effects of prescription drug abuse |
| Q37098953 | Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates |
| Q34221937 | Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review |
| Q28484279 | Organization of GABAergic synaptic circuits in the rat ventral tegmental area |
| Q33961959 | Patients with combat-related and war-related posttraumatic stress disorder 10 years after diagnosis |
| Q36114186 | Perceived Stress, Alexithymia, and Psychological Health as Predictors of Sedative Abuse |
| Q34381277 | Perceptions of benzodiazepine dependence among women age 65 and older |
| Q57689410 | Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users |
| Q33582092 | Pharmacological strategies for detoxification |
| Q55362163 | Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors. |
| Q53412548 | Polypharmacy and patterns of prescription medication use among cancer survivors. |
| Q47609325 | Pregabalin Use Among Users of Illicit Drugs: A Cross-Sectional Survey in Southern Germany |
| Q28074617 | Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review |
| Q30888124 | Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data |
| Q41690453 | Prevalence of self-medication practice with herbal products among non-psychotic psychiatric patients from southeastern Serbia: A cross-sectional study |
| Q36739694 | Progress in neuroprotective strategies for preventing epilepsy. |
| Q48957291 | Psychiatric Aspects of Heart and Lung Disease in Critical Care |
| Q37726988 | Recommendations for pharmacological management of inpatient aggression in children and adolescents. |
| Q33574884 | Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes |
| Q38078343 | Relevant issues in pharmacotherapy of psycho-cutaneous disorders |
| Q36588309 | Sleep Quality Among Psychiatry Residents |
| Q33685284 | Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting |
| Q47624983 | The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. |
| Q33739895 | The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study |
| Q37775610 | The relationship between benzodiazepine use and traffic accidents: A systematic literature review. |
| Q37130365 | The role of a prescription in anxiety medication use, abuse, and dependence |
| Q30471700 | Tolerance to allopregnanolone with focus on the GABA-A receptor |
| Q38901939 | Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin |
| Q38724675 | University student perceptions about the motives for and consequences of nonmedical use of prescription drugs (NMUPD). |
| Q38687615 | Withdrawing Benzodiazepines in Patients With Anxiety Disorders |
Search more.